Skip to content

Author

Jia Fan

We have 3 of 96 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Integrating Magnetic Resonance Imaging-Based Deep Learning and Radiomics to Predict Treatment Response in Hepatocellular Carcinoma Receiving Combined Systemic and Locoregional Therapies: A Multicenter Study

Abstract Background Although combining systemic and locoregional therapies has improved outcomes for hepatocellular carcinoma (HCC), identifying appropriate candidates remains challenging because no reliable tool predicts response. Methods This retrospective multicenter study enrolled 334 HCC patients who received firs...

Lu-Na Wang, Shi-Qi Zhou, Fei Li et al. · 0 citations
Clinical trial Aug 2026

Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial.

BACKGROUND Resection might offer additional benefit in patients with advanced-stage hepatocellular carcinoma treated with systemic therapy. However, high-quality evidence supporting the procedure is absent. We aimed to establish whether resection can provide survival benefit in patients with advanced hepatocellular car...

Hui-Chuan Sun, Xiao-Dong Zhu, Feng Shen et al. · 3 citations · ⚡1
Jul 2026

FGFR2 Fusion-Driven CXCL3 Downregulation Attenuates Neutrophil Recruitment in Intrahepatic Cholangiocarcinoma.

Mechanistic insights are provided into the paradox between the oncogenic properties of FGFR2 fusion and favorable clinical outcomes in FGFR2 fusion-positive iCCA, and a potential strategy to optimize FGFR2-targeted therapies is suggested.

Tao Zhu, Jia-Cheng Lu, Yan-Zi Pei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.